Skip to content

Clinical trials

Phase 2 Pancreatic Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 2 Country / region: Switzerland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20111
20172
20191
20201
20211
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Bayer1
Boehringer Ingelheim1
Central European Society for Anticancer Drug Research1
European Organisation for Research and Treatment of Cancer - EORTC1
Interdisziplinare Arbeitsgruppe Gastrointestinaler Tumore der Deutschen Krebsgesellschaft1
Kantonsspital Aarau1
Ludwig-Maximilians - University of Munich1
Merck Sharp & Dohme LLC1
NovoCure Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms13
Biliary Tract Neoplasms3
Stomach Neoplasms3
Urinary Bladder Neoplasms3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Endometrial Neoplasms2
Esophageal Neoplasms2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.